 Bennett Chin
Concepts (300)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Radiopharmaceuticals | 26 | 2022 | 191 | 3.250 |
Why?
| | Tomography, Emission-Computed, Single-Photon | 19 | 2014 | 99 | 2.180 |
Why?
| | Neuroendocrine Tumors | 3 | 2024 | 110 | 1.580 |
Why?
| | Fluorodeoxyglucose F18 | 15 | 2019 | 151 | 1.520 |
Why?
| | Iodine Radioisotopes | 8 | 2023 | 139 | 1.320 |
Why?
| | Organometallic Compounds | 6 | 2023 | 115 | 1.280 |
Why?
| | Positron-Emission Tomography | 8 | 2024 | 309 | 1.060 |
Why?
| | Tomography, Emission-Computed | 9 | 2004 | 68 | 1.040 |
Why?
| | Radionuclide Imaging | 14 | 2023 | 117 | 0.720 |
Why?
| | Positron Emission Tomography Computed Tomography | 6 | 2025 | 116 | 0.700 |
Why?
| | Image Enhancement | 4 | 2007 | 194 | 0.700 |
Why?
| | Heart | 8 | 2014 | 627 | 0.640 |
Why?
| | 3-Iodobenzylguanidine | 3 | 2023 | 8 | 0.620 |
Why?
| | Fluorine Radioisotopes | 3 | 2017 | 13 | 0.590 |
Why?
| | Prostatic Neoplasms | 5 | 2025 | 1054 | 0.580 |
Why?
| | Thallium Radioisotopes | 5 | 1999 | 8 | 0.540 |
Why?
| | Phantoms, Imaging | 8 | 2025 | 151 | 0.510 |
Why?
| | Contrast Media | 6 | 2014 | 479 | 0.500 |
Why?
| | Urinary Retention | 1 | 2016 | 23 | 0.500 |
Why?
| | Carcinosarcoma | 1 | 2016 | 23 | 0.490 |
Why?
| | Leucine | 1 | 2017 | 117 | 0.490 |
Why?
| | Paraganglioma | 3 | 2023 | 53 | 0.490 |
Why?
| | Oxyquinoline | 2 | 2007 | 3 | 0.470 |
Why?
| | Neoplasms, Second Primary | 1 | 2016 | 98 | 0.460 |
Why?
| | Carcinoma, Squamous Cell | 2 | 2016 | 643 | 0.420 |
Why?
| | Whole Body Imaging | 2 | 2014 | 26 | 0.410 |
Why?
| | Gated Blood-Pool Imaging | 2 | 2007 | 4 | 0.410 |
Why?
| | Leukemia L1210 | 2 | 2012 | 7 | 0.410 |
Why?
| | Gallium Radioisotopes | 2 | 2023 | 14 | 0.400 |
Why?
| | Retinal Dehydrogenase | 1 | 2012 | 29 | 0.360 |
Why?
| | Chloroquine | 1 | 2012 | 53 | 0.360 |
Why?
| | Technetium Tc 99m Sestamibi | 8 | 2016 | 13 | 0.350 |
Why?
| | Myocardial Infarction | 3 | 2007 | 1067 | 0.340 |
Why?
| | Isoenzymes | 1 | 2012 | 296 | 0.340 |
Why?
| | Phenylalanine | 1 | 2011 | 68 | 0.340 |
Why?
| | Thyroid Neoplasms | 3 | 2016 | 327 | 0.330 |
Why?
| | Adrenal Gland Neoplasms | 3 | 2023 | 90 | 0.320 |
Why?
| | Pheochromocytoma | 2 | 2023 | 58 | 0.320 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2007 | 376 | 0.310 |
Why?
| | Coronary Circulation | 5 | 2002 | 134 | 0.310 |
Why?
| | Electrocardiography | 2 | 2014 | 628 | 0.300 |
Why?
| | Aldehyde Dehydrogenase | 1 | 2009 | 100 | 0.290 |
Why?
| | Tissue Distribution | 3 | 2017 | 328 | 0.290 |
Why?
| | Aldehydes | 1 | 2009 | 146 | 0.290 |
Why?
| | Sensitivity and Specificity | 7 | 2017 | 1977 | 0.280 |
Why?
| | Radiation Dosage | 3 | 2015 | 192 | 0.270 |
Why?
| | Breast Neoplasms | 3 | 2017 | 2272 | 0.260 |
Why?
| | Lung Neoplasms | 3 | 2016 | 2568 | 0.250 |
Why?
| | Tomography, X-Ray Computed | 7 | 2008 | 2771 | 0.250 |
Why?
| | Image Interpretation, Computer-Assisted | 2 | 2005 | 277 | 0.240 |
Why?
| | Gamma Cameras | 1 | 2005 | 6 | 0.230 |
Why?
| | Bone Marrow Transplantation | 1 | 2007 | 292 | 0.230 |
Why?
| | Radiometry | 2 | 2017 | 54 | 0.230 |
Why?
| | Bone Marrow Cells | 1 | 2007 | 317 | 0.230 |
Why?
| | Urea | 1 | 2025 | 83 | 0.230 |
Why?
| | Humans | 48 | 2025 | 142526 | 0.230 |
Why?
| | Gastrointestinal Neoplasms | 1 | 2006 | 75 | 0.220 |
Why?
| | Intercostal Muscles | 1 | 2004 | 4 | 0.220 |
Why?
| | Feasibility Studies | 6 | 2009 | 1047 | 0.220 |
Why?
| | Indium Radioisotopes | 3 | 1999 | 12 | 0.220 |
Why?
| | Neoplasm Recurrence, Local | 5 | 2004 | 1087 | 0.220 |
Why?
| | Somatostatin | 3 | 2016 | 57 | 0.210 |
Why?
| | Stomach Neoplasms | 2 | 2022 | 118 | 0.210 |
Why?
| | Data Curation | 1 | 2024 | 19 | 0.210 |
Why?
| | Vocal Cord Paralysis | 1 | 2003 | 28 | 0.210 |
Why?
| | Vocal Cords | 1 | 2003 | 32 | 0.200 |
Why?
| | Thyrotropin | 1 | 2004 | 116 | 0.200 |
Why?
| | Digestive System Neoplasms | 1 | 2003 | 9 | 0.200 |
Why?
| | Magnetic Resonance Imaging | 9 | 2025 | 3776 | 0.200 |
Why?
| | Lysine | 1 | 2025 | 301 | 0.200 |
Why?
| | Mesenchymal Stem Cell Transplantation | 1 | 2003 | 59 | 0.200 |
Why?
| | Carcinoma, Papillary | 1 | 2003 | 80 | 0.200 |
Why?
| | Fallopian Tube Neoplasms | 1 | 2002 | 19 | 0.190 |
Why?
| | Myocardial Contraction | 2 | 2002 | 299 | 0.190 |
Why?
| | Atherosclerosis | 1 | 2007 | 402 | 0.190 |
Why?
| | Lutetium | 1 | 2022 | 6 | 0.190 |
Why?
| | Paraganglioma, Extra-Adrenal | 1 | 2022 | 6 | 0.190 |
Why?
| | Radioisotopes | 1 | 2022 | 33 | 0.190 |
Why?
| | Myocardial Stunning | 1 | 2002 | 4 | 0.190 |
Why?
| | Receptors, Peptide | 1 | 2022 | 19 | 0.190 |
Why?
| | Dobutamine | 1 | 2002 | 26 | 0.190 |
Why?
| | Image Processing, Computer-Assisted | 5 | 2025 | 771 | 0.190 |
Why?
| | Intestinal Neoplasms | 1 | 2022 | 31 | 0.180 |
Why?
| | Animals | 19 | 2025 | 37697 | 0.180 |
Why?
| | Cell Line, Tumor | 3 | 2017 | 3546 | 0.170 |
Why?
| | Artificial Intelligence | 1 | 2025 | 353 | 0.170 |
Why?
| | Diabetic Nephropathies | 1 | 2024 | 302 | 0.170 |
Why?
| | Male | 28 | 2025 | 70910 | 0.160 |
Why?
| | Mice | 8 | 2019 | 18172 | 0.160 |
Why?
| | Technetium Tc 99m Aggregated Albumin | 2 | 1999 | 6 | 0.160 |
Why?
| | Female | 29 | 2025 | 76624 | 0.160 |
Why?
| | Oxygen Consumption | 1 | 2003 | 714 | 0.160 |
Why?
| | Leukoencephalopathy, Progressive Multifocal | 1 | 1999 | 38 | 0.150 |
Why?
| | Ventilation-Perfusion Ratio | 1 | 1999 | 11 | 0.150 |
Why?
| | Stem Cells | 1 | 2003 | 612 | 0.150 |
Why?
| | Receptors, Somatostatin | 1 | 1999 | 25 | 0.150 |
Why?
| | Hormone Antagonists | 1 | 1999 | 34 | 0.150 |
Why?
| | Thymus Neoplasms | 1 | 1999 | 26 | 0.150 |
Why?
| | Thymoma | 1 | 1999 | 36 | 0.150 |
Why?
| | Radiation Pneumonitis | 1 | 1999 | 31 | 0.150 |
Why?
| | AIDS-Related Opportunistic Infections | 1 | 1999 | 128 | 0.150 |
Why?
| | Middle Aged | 20 | 2025 | 35049 | 0.140 |
Why?
| | Metal Nanoparticles | 1 | 2019 | 85 | 0.140 |
Why?
| | Sodium Pertechnetate Tc 99m | 1 | 1997 | 4 | 0.140 |
Why?
| | Coronary Disease | 2 | 2000 | 373 | 0.140 |
Why?
| | Dipyridamole | 2 | 2002 | 29 | 0.140 |
Why?
| | Myocardium | 1 | 2003 | 924 | 0.130 |
Why?
| | Amyotrophic Lateral Sclerosis | 1 | 1998 | 101 | 0.130 |
Why?
| | Hematoma | 1 | 1997 | 55 | 0.130 |
Why?
| | Frontal Lobe | 1 | 1998 | 161 | 0.130 |
Why?
| | Cardiac Surgical Procedures | 1 | 2003 | 588 | 0.130 |
Why?
| | Isotope Labeling | 2 | 2011 | 81 | 0.130 |
Why?
| | Pancreatic Neoplasms | 2 | 2022 | 895 | 0.130 |
Why?
| | Smoking | 1 | 2004 | 1579 | 0.130 |
Why?
| | Head and Neck Neoplasms | 1 | 2022 | 558 | 0.130 |
Why?
| | Transurethral Resection of Prostate | 1 | 2016 | 2 | 0.130 |
Why?
| | Safety | 1 | 2018 | 356 | 0.120 |
Why?
| | Brain Neoplasms | 2 | 2019 | 1295 | 0.120 |
Why?
| | Neoplasms | 1 | 2012 | 2761 | 0.120 |
Why?
| | Diagnostic Imaging | 1 | 2019 | 331 | 0.120 |
Why?
| | Parathyroid Diseases | 1 | 2015 | 2 | 0.120 |
Why?
| | Vasodilator Agents | 2 | 2002 | 330 | 0.120 |
Why?
| | Molecular Structure | 1 | 2017 | 503 | 0.120 |
Why?
| | Thyroid Nodule | 1 | 2016 | 55 | 0.110 |
Why?
| | Four-Dimensional Computed Tomography | 1 | 2015 | 38 | 0.110 |
Why?
| | Sarcoidosis | 1 | 1997 | 162 | 0.110 |
Why?
| | Androstenes | 1 | 2015 | 17 | 0.110 |
Why?
| | Stroke Volume | 2 | 1997 | 606 | 0.110 |
Why?
| | Phenylthiohydantoin | 1 | 2015 | 44 | 0.110 |
Why?
| | Dementia | 1 | 1998 | 281 | 0.110 |
Why?
| | Ventricular Function, Right | 1 | 1997 | 288 | 0.110 |
Why?
| | Taxoids | 1 | 2015 | 105 | 0.110 |
Why?
| | Neoplasms, Radiation-Induced | 1 | 2015 | 98 | 0.110 |
Why?
| | Prostatic Neoplasms, Castration-Resistant | 1 | 2015 | 53 | 0.110 |
Why?
| | Mediastinum | 1 | 2014 | 22 | 0.110 |
Why?
| | Dogs | 4 | 2003 | 426 | 0.100 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1267 | 0.100 |
Why?
| | Prednisone | 1 | 2015 | 231 | 0.100 |
Why?
| | Ventricular Function, Left | 1 | 1997 | 517 | 0.100 |
Why?
| | Coronary Stenosis | 3 | 2002 | 38 | 0.100 |
Why?
| | Cardiomyopathies | 1 | 1997 | 333 | 0.100 |
Why?
| | Bone and Bones | 3 | 2009 | 314 | 0.100 |
Why?
| | Healthy Volunteers | 1 | 2014 | 213 | 0.100 |
Why?
| | Radiographic Image Interpretation, Computer-Assisted | 1 | 2014 | 119 | 0.100 |
Why?
| | Aged | 12 | 2025 | 25117 | 0.090 |
Why?
| | Adult | 13 | 2024 | 39715 | 0.090 |
Why?
| | Carbon Radioisotopes | 1 | 2011 | 29 | 0.090 |
Why?
| | Swine | 6 | 2003 | 832 | 0.090 |
Why?
| | Hemodynamics | 1 | 1996 | 1114 | 0.080 |
Why?
| | Organ Specificity | 2 | 2019 | 310 | 0.080 |
Why?
| | Lymph Nodes | 2 | 2003 | 497 | 0.080 |
Why?
| | Neoplasm Metastasis | 2 | 2004 | 676 | 0.080 |
Why?
| | Time Factors | 2 | 2014 | 7006 | 0.080 |
Why?
| | Thyroid Gland | 2 | 2016 | 92 | 0.080 |
Why?
| | Drug Resistance, Neoplasm | 2 | 2015 | 851 | 0.080 |
Why?
| | Prostate-Specific Antigen | 3 | 2022 | 166 | 0.080 |
Why?
| | Mice, Nude | 1 | 2012 | 701 | 0.080 |
Why?
| | Gadolinium | 4 | 2002 | 86 | 0.080 |
Why?
| | Reproducibility of Results | 3 | 2007 | 3362 | 0.080 |
Why?
| | K562 Cells | 1 | 2009 | 95 | 0.080 |
Why?
| | Blotting, Western | 1 | 2012 | 1220 | 0.070 |
Why?
| | Metabolic Clearance Rate | 1 | 2008 | 116 | 0.070 |
Why?
| | Glioblastoma | 1 | 2012 | 347 | 0.070 |
Why?
| | Parathyroid Neoplasms | 2 | 1997 | 12 | 0.070 |
Why?
| | Diabetes Mellitus, Type 1 | 1 | 2024 | 3819 | 0.070 |
Why?
| | Mice, Inbred C57BL | 3 | 2007 | 5967 | 0.070 |
Why?
| | Octreotide | 2 | 1999 | 26 | 0.070 |
Why?
| | Neoplasm Staging | 2 | 2002 | 1404 | 0.060 |
Why?
| | Adenoma | 3 | 1998 | 218 | 0.060 |
Why?
| | Injections, Intravenous | 2 | 2003 | 203 | 0.060 |
Why?
| | Antineoplastic Agents | 2 | 2015 | 2167 | 0.060 |
Why?
| | Drug Delivery Systems | 1 | 2009 | 362 | 0.060 |
Why?
| | Glutamate Carboxypeptidase II | 1 | 2025 | 8 | 0.060 |
Why?
| | Analysis of Variance | 1 | 2008 | 1313 | 0.060 |
Why?
| | Molecular Probe Techniques | 1 | 2005 | 8 | 0.060 |
Why?
| | Miniaturization | 1 | 2005 | 22 | 0.060 |
Why?
| | Antigens, Surface | 1 | 2025 | 156 | 0.060 |
Why?
| | X-Ray Microtomography | 1 | 2025 | 103 | 0.060 |
Why?
| | Molecular Biology | 1 | 2005 | 60 | 0.060 |
Why?
| | Equipment Failure Analysis | 1 | 2005 | 130 | 0.060 |
Why?
| | Iodides | 1 | 2004 | 11 | 0.060 |
Why?
| | Retrospective Studies | 5 | 2016 | 16626 | 0.060 |
Why?
| | Citric Acid Cycle | 1 | 2024 | 58 | 0.050 |
Why?
| | Theophylline | 1 | 2004 | 41 | 0.050 |
Why?
| | Phosphodiesterase Inhibitors | 1 | 2004 | 75 | 0.050 |
Why?
| | Models, Animal | 2 | 2003 | 392 | 0.050 |
Why?
| | Rats, Wistar | 1 | 2025 | 453 | 0.050 |
Why?
| | Thyroglobulin | 1 | 2004 | 28 | 0.050 |
Why?
| | Biomarkers, Tumor | 2 | 2023 | 1262 | 0.050 |
Why?
| | Equipment Design | 1 | 2005 | 530 | 0.050 |
Why?
| | Artifacts | 1 | 2004 | 135 | 0.050 |
Why?
| | Neck | 1 | 2003 | 106 | 0.050 |
Why?
| | Metanephrine | 1 | 2023 | 2 | 0.050 |
Why?
| | Inhalation | 1 | 2003 | 29 | 0.050 |
Why?
| | Exhalation | 1 | 2003 | 29 | 0.050 |
Why?
| | Heterocyclic Compounds, 1-Ring | 1 | 2022 | 6 | 0.050 |
Why?
| | Chromogranin A | 1 | 2023 | 42 | 0.050 |
Why?
| | Gadolinium DTPA | 1 | 2002 | 71 | 0.050 |
Why?
| | Dipeptides | 1 | 2022 | 56 | 0.050 |
Why?
| | Prospective Studies | 3 | 2025 | 7862 | 0.050 |
Why?
| | Movement | 1 | 2004 | 291 | 0.040 |
Why?
| | Clinical Trials as Topic | 1 | 2006 | 1037 | 0.040 |
Why?
| | Intestines | 1 | 2004 | 355 | 0.040 |
Why?
| | Aged, 80 and over | 4 | 2015 | 8020 | 0.040 |
Why?
| | Oxidation-Reduction | 1 | 2024 | 1084 | 0.040 |
Why?
| | Myocardial Ischemia | 1 | 2002 | 279 | 0.040 |
Why?
| | Recombinant Proteins | 1 | 2004 | 1364 | 0.040 |
Why?
| | Radioimmunodetection | 1 | 1999 | 1 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2007 | 3081 | 0.040 |
Why?
| | Lymphocyte Activation | 1 | 2003 | 1142 | 0.040 |
Why?
| | Organotechnetium Compounds | 1 | 1998 | 12 | 0.040 |
Why?
| | Esophageal Neoplasms | 1 | 2003 | 343 | 0.040 |
Why?
| | Bone Neoplasms | 2 | 1999 | 249 | 0.040 |
Why?
| | Cell Movement | 1 | 2003 | 969 | 0.040 |
Why?
| | Pleural Neoplasms | 1 | 1999 | 27 | 0.040 |
Why?
| | Salvage Therapy | 1 | 1999 | 155 | 0.040 |
Why?
| | Optical Imaging | 1 | 2019 | 64 | 0.040 |
Why?
| | Gardner Syndrome | 1 | 1998 | 2 | 0.040 |
Why?
| | Osteoma | 1 | 1998 | 2 | 0.040 |
Why?
| | Mediastinal Neoplasms | 1 | 1999 | 51 | 0.040 |
Why?
| | Gold | 1 | 2019 | 119 | 0.030 |
Why?
| | Retroperitoneal Space | 1 | 1997 | 18 | 0.030 |
Why?
| | Pilot Projects | 1 | 2003 | 1829 | 0.030 |
Why?
| | Carcinoid Tumor | 1 | 1997 | 22 | 0.030 |
Why?
| | Cardiac Volume | 1 | 1997 | 15 | 0.030 |
Why?
| | Duodenal Neoplasms | 1 | 1997 | 24 | 0.030 |
Why?
| | Cysteine | 1 | 1998 | 210 | 0.030 |
Why?
| | HIV-1 | 1 | 2003 | 890 | 0.030 |
Why?
| | Ventricular Function | 1 | 1997 | 57 | 0.030 |
Why?
| | Choristoma | 1 | 1996 | 21 | 0.030 |
Why?
| | Rats | 1 | 2025 | 5585 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1500 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2019 | 747 | 0.030 |
Why?
| | Cerebrovascular Circulation | 1 | 1998 | 271 | 0.030 |
Why?
| | Pulmonary Embolism | 1 | 1999 | 239 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 2007 | 4483 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1229 | 0.030 |
Why?
| | Magnetic Resonance Imaging, Cine | 1 | 1997 | 211 | 0.030 |
Why?
| | Incidental Findings | 1 | 2016 | 81 | 0.030 |
Why?
| | Deoxyglucose | 1 | 1995 | 50 | 0.030 |
Why?
| | Thoracic Neoplasms | 1 | 1995 | 39 | 0.030 |
Why?
| | Radiography | 2 | 2015 | 846 | 0.030 |
Why?
| | Survival Analysis | 1 | 2018 | 1328 | 0.030 |
Why?
| | Colorectal Neoplasms | 1 | 2003 | 824 | 0.030 |
Why?
| | Kallikreins | 1 | 2015 | 26 | 0.030 |
Why?
| | Abiraterone Acetate | 1 | 2015 | 15 | 0.030 |
Why?
| | Diagnosis, Differential | 1 | 1999 | 1501 | 0.030 |
Why?
| | Lung | 2 | 1999 | 4078 | 0.030 |
Why?
| | Benzamides | 1 | 2015 | 222 | 0.030 |
Why?
| | Nitriles | 1 | 2015 | 192 | 0.030 |
Why?
| | Infusions, Intra-Arterial | 1 | 1993 | 62 | 0.020 |
Why?
| | Infusion Pumps, Implantable | 1 | 1993 | 26 | 0.020 |
Why?
| | Hepatic Artery | 1 | 1993 | 52 | 0.020 |
Why?
| | Disease-Free Survival | 1 | 2015 | 716 | 0.020 |
Why?
| | Exercise Test | 1 | 1996 | 623 | 0.020 |
Why?
| | Follow-Up Studies | 2 | 1999 | 5270 | 0.020 |
Why?
| | Risk Factors | 3 | 2015 | 10593 | 0.020 |
Why?
| | Antibodies, Monoclonal | 1 | 1999 | 1471 | 0.020 |
Why?
| | Cardiac Catheterization | 1 | 1996 | 547 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2015 | 914 | 0.020 |
Why?
| | Biopsy | 1 | 2016 | 1081 | 0.020 |
Why?
| | Erythrocytes | 1 | 1997 | 701 | 0.020 |
Why?
| | Treatment Outcome | 2 | 2018 | 11298 | 0.020 |
Why?
| | Proportional Hazards Models | 1 | 2015 | 1284 | 0.020 |
Why?
| | Prognosis | 1 | 1999 | 4112 | 0.020 |
Why?
| | Carcinoma, Non-Small-Cell Lung | 1 | 1999 | 1128 | 0.020 |
Why?
| | Prevalence | 1 | 2016 | 2817 | 0.020 |
Why?
| | HIV Infections | 1 | 2003 | 3003 | 0.020 |
Why?
| | Case-Control Studies | 1 | 1996 | 3604 | 0.020 |
Why?
| | Incidence | 1 | 2015 | 2826 | 0.020 |
Why?
| | Young Adult | 1 | 2024 | 13878 | 0.020 |
Why?
| | Brain | 1 | 1999 | 2875 | 0.020 |
Why?
| | Disease Progression | 1 | 2015 | 2831 | 0.020 |
Why?
| | Risk Assessment | 1 | 2015 | 3562 | 0.010 |
Why?
| | Subtraction Technique | 1 | 2004 | 25 | 0.010 |
Why?
| | Abdominal Neoplasms | 1 | 2004 | 47 | 0.010 |
Why?
| | Cyclic AMP | 1 | 2004 | 215 | 0.010 |
Why?
| | Adolescent | 2 | 2018 | 22326 | 0.010 |
Why?
| | HIV Seropositivity | 1 | 2003 | 119 | 0.010 |
Why?
| | Diagnostic Errors | 1 | 2004 | 176 | 0.010 |
Why?
| | Viremia | 1 | 2003 | 156 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 985 | 0.010 |
Why?
| | Drug Evaluation, Preclinical | 1 | 2002 | 194 | 0.010 |
Why?
| | Coronary Vessels | 1 | 2002 | 250 | 0.010 |
Why?
| | Virus Replication | 1 | 2003 | 542 | 0.010 |
Why?
| | Angioplasty, Balloon, Coronary | 1 | 2000 | 144 | 0.010 |
Why?
| | Prostatectomy | 1 | 1999 | 102 | 0.010 |
Why?
| | Vasodilation | 1 | 2002 | 513 | 0.010 |
Why?
| | Influenza Vaccines | 1 | 2003 | 553 | 0.010 |
Why?
| | Intestinal Mucosa | 1 | 2004 | 654 | 0.010 |
Why?
| | Zollinger-Ellison Syndrome | 1 | 1997 | 2 | 0.010 |
Why?
| | Gastrins | 1 | 1997 | 8 | 0.010 |
Why?
| | Radionuclide Angiography | 1 | 1997 | 3 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2004 | 4167 | 0.010 |
Why?
| | Research Design | 1 | 2002 | 1113 | 0.010 |
Why?
| | Esophagus | 1 | 1996 | 265 | 0.010 |
Why?
| | Heart Diseases | 1 | 1997 | 339 | 0.010 |
Why?
| | Technetium | 1 | 1993 | 10 | 0.010 |
Why?
| | Microspheres | 1 | 1993 | 142 | 0.010 |
Why?
| | Liver | 1 | 1993 | 1848 | 0.000 |
Why?
|
|
Chin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|